METHOD OF ALCOHOLIC ABSTINENCE SYNDROME REDUCTION Russian patent published in 2008 - IPC A61K35/02 A61K33/00 A61K31/194 A61P39/06 A61P25/32 

FIELD: medicine; psychiatry.

SUBSTANCE: method of alcoholic abstinence syndrome (AAS) reduction includes pharmacotherapy, that is oral introduction of sorbent powder suspension Polysorb MP in amount 50-150 ml of concentration 1-1.5 g of powder per kg of body weight. Then 1000 ml of plasma-substituting agent Plasma-lyt 148 or Rheamberyn is drop-by-drop intravenously introduced in daily dose 10 mg/kg. It is accompanied with hydrocolonotherapy with Polysorb MP concentrated not more than 100-200 mg per 1 kg of body weight followed with rectal insufflations of gaseous ozone-oxygen mixture containing ozone concentrated 10-60 ml/l and volume up to 150 ml. Intravenous injection of Plasma-lyt 148 or Rheamberyn is accompanied with additional intravenous bolus injection of polyvitamin agent Cernevit in 5 ml of injection water or 5% glucose solution. Additionally psychopathological and neurovegetative disorders are corrected.

EFFECT: more rapid elimination of disorders associated with abstinence syndrome without by-effects and complications.

5 cl, 1 ex